{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:28Z","timestamp":1792601488916,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":720,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jpad.2022.73","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T08:08:42Z","timestamp":1662019722000},"page":"679-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data"],"prefix":"10.1016","volume":"9","author":[{"given":"Zohara","family":"Sternberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Podolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hojnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2022.73_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer's disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.14283\/jpad.2022.73_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiological reviews"},{"issue":"5","key":"10.14283\/jpad.2022.73_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.cortex.2012.06.004","article-title":"Executive functions in mild cognitive impairment: emergence and breakdown of neural plasticity","volume":"49","author":"Clement","year":"2013","journal-title":"Cortex"},{"issue":"6","key":"10.14283\/jpad.2022.73_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000322112","article-title":"Functional alterations in brain activation and deactivation in mild cognitive impairment in response to a graded working memory challenge","volume":"30","author":"Kochan","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/NDT.S2154","article-title":"Strategies for molecular imaging dementia and neurodegenerative diseases","volume":"4","author":"Schaller","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"10.14283\/jpad.2022.73_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00259-003-1202-5","article-title":"PET-based molecular imaging in neuroscience","volume":"30","author":"Jacobs","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.14283\/jpad.2022.73_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncom.2019.00072","article-title":"Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers","volume":"13","author":"Gupta","year":"2019","journal-title":"Front Comput Neurosci"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"12","key":"10.14283\/jpad.2022.73_bib9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib10","doi-asserted-by":"crossref","first-page":"e0191345","DOI":"10.1371\/journal.pone.0191345","article-title":"Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms","volume":"13","author":"Smith","year":"2018","journal-title":"PLoS One"},{"key":"10.14283\/jpad.2022.73_bib11","first-page":"404","article-title":"Mild Cognitive Impairment","volume":"22","author":"Petersen","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"10","key":"10.14283\/jpad.2022.73_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/WNL.0b013e3181f11d85","article-title":"Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging","volume":"75","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.73_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sleep.2018.09.001","article-title":"Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications","volume":"52","author":"Burke","year":"2018","journal-title":"Sleep Med"},{"issue":"9","key":"10.14283\/jpad.2022.73_bib14","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"11","key":"10.14283\/jpad.2022.73_bib15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00127-018-1581-3","article-title":"Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis","volume":"53","author":"Pal","year":"2018","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"10","key":"10.14283\/jpad.2022.73_bib16","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-142178","article-title":"Depression and mild cognitive impairment in the general population: results of the Heinz Nixdorf recall study","volume":"45","author":"Dlugaj","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.14283\/jpad.2022.73_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jamainternmed.2014.8164","article-title":"Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs","volume":"175","author":"Mossello","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.14283\/jpad.2022.73_bib19","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.hjh.0000244961.69985.05","article-title":"Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints","volume":"24","author":"Hanon","year":"2006","journal-title":"J Hypertens"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3233\/JAD-170238","article-title":"Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study","volume":"59","author":"Edwards","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/M17-1529","article-title":"Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review","volume":"168","author":"Fink","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.14283\/jpad.2022.73_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"10.14283\/jpad.2022.73_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Suppl 1","key":"10.14283\/jpad.2022.73_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.14283\/jpad.2022.73_bib25","first-page":"684","article-title":"Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease","volume":"14","author":"Rizvi","year":"2015","journal-title":"EXCLI J"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"10.14283\/jpad.2022.73_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jamda.2020.12.019","article-title":"Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis","volume":"22","author":"den Brok","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"10.14283\/jpad.2022.73_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.14336\/AD.2020.1111","article-title":"Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review","volume":"12","author":"Yang","year":"2021","journal-title":"Aging Dis"},{"key":"10.14283\/jpad.2022.73_bib30","doi-asserted-by":"crossref","first-page":"103414","DOI":"10.1016\/j.mcn.2019.103414","article-title":"Role of GPCR signaling and calcium dysregulation in Alzheimer's disease","volume":"101","author":"Sushma","year":"2019","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"10.14283\/jpad.2022.73_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","article-title":"Dysregulation of neuronal calcium homeostasis in Alzheimer's disease \u2014 A therapeutic opportunity?","volume":"483","author":"Popugaeva","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.14283\/jpad.2022.73_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.24.002.2009","article-title":"Susceptibility to Calcium Dysregulation during Brain Aging","volume":"1","author":"Kumar","year":"2009","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"10.14283\/jpad.2022.73_bib33","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bbamcr.2013.01.012","article-title":"Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment","volume":"1833","author":"Jaworska","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"5264","key":"10.14283\/jpad.2022.73_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1126\/science.272.5264.1017","article-title":"Increase in single L-type calcium channels in hippocampal neurons during aging","volume":"272","author":"Thibault","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"3\u20134","key":"10.14283\/jpad.2022.73_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower Abeta accumulation by targeting both the production and the clearance of Abeta across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol Med"},{"issue":"2\u20133","key":"10.14283\/jpad.2022.73_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jphysparis.2005.12.079","article-title":"Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease","volume":"99","author":"Disterhoft","year":"2006","journal-title":"J Physiol Paris"},{"issue":"18","key":"10.14283\/jpad.2022.73_bib38","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.14283\/jpad.2022.73_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/080370598438999","article-title":"The pharmacological properties of lipophilic calcium antagonists","volume":"2","author":"van Zwieten","year":"1998","journal-title":"Blood Press Suppl"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1291\/hypres.18.47","article-title":"Effects of Ca-antagonists on oxidative susceptibility of low density lipoprotein (LDL)","volume":"18","author":"Yoshida","year":"1995","journal-title":"Hypertens Res"},{"issue":"8","key":"10.14283\/jpad.2022.73_bib41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/CIRCULATIONAHA.117.027448","article-title":"Cerebral Perfusion and the Risk of Dementia: A Population-Based Study","volume":"136","author":"Wolters","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12576-017-0525-0","article-title":"Relationship between cognitive function and regulation of cerebral blood flow","volume":"67","author":"Ogoh","year":"2017","journal-title":"J Physiol Sci"},{"issue":"6","key":"10.14283\/jpad.2022.73_bib43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/HJH.0000000000000868","article-title":"Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies","volume":"34","author":"Tully","year":"2016","journal-title":"J Hypertens"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2009-0925","article-title":"Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization","volume":"16","author":"Zhao","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib45","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1038\/s41598-018-27995-w","article-title":"Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodiumpotassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B","volume":"8","author":"Hampel","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.14283\/jpad.2022.73_bib46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/EDE.0000000000001245","article-title":"Comparison of Antihypertensive Drug Classes for Dementia Prevention","volume":"31","author":"Walker","year":"2020","journal-title":"Epidemiology"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jalz.2011.03.010","article-title":"Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study","volume":"8","author":"Yasar","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.73_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2019.02.005","article-title":"Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease","volume":"404","author":"Coelho","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.14283\/jpad.2022.73_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","article-title":"Prazosin, an alpha(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease","volume":"34","author":"Katsouri","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12916-016-0725-0","article-title":"Neuroimaging in vascular cognitive impairment: a state-of-the-art review","volume":"14","author":"Heiss","year":"2016","journal-title":"BMC Med"},{"issue":"2","key":"10.14283\/jpad.2022.73_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.ki.5002648","article-title":"Bias in clinical research","volume":"73","author":"Tripepi","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.14283\/jpad.2022.73_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"issue":"1","key":"10.14283\/jpad.2022.73_bib54","first-page":"73","article-title":"Angiotensin-Receptor Blockers and the Risk of Alzheimer s Disease: A Meta-analysis","volume":"16","author":"Oscanoa","year":"2021","journal-title":"Curr Rev Clin Exp Pharmacol"},{"issue":"3","key":"10.14283\/jpad.2022.73_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1871525713666150310110934","article-title":"Resistant hypertension in the elderly-second line treatments: aldosterone antagonists, central alpha-agonist agents, alpha-adrenergic receptor blockers, direct vasodilators, and exogenous nitric oxide donors","volume":"12","author":"Musso","year":"2015","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"2","key":"10.14283\/jpad.2022.73_bib56","doi-asserted-by":"crossref","first-page":"14A","DOI":"10.1016\/0002-9149(86)91001-5","article-title":"Cellular mechanism of action of loop diuretics: implications for drug effectiveness and adverse effects","volume":"57","author":"Feig","year":"1986","journal-title":"Am J Cardiol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:41:54Z","timestamp":1736469714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2274580724002772"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.73","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.73","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}